|
|
Article: Abbott Laboratories to Market New Test for Retroviruses
- Article from:
- PR Newswire
- Article date:
- August 18, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
First Combination Test to Detect Both HTLV-I and HTLV-II
ABBOTT PARK, Ill., Aug. 18 /PRNewswire/ -- Abbott Laboratories (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has licensed for marketing the first blood screening test for detection of antibodies to both Human T-Lymphotropic Virus Types I and II (HTLV-I/HTLV-II). Abbott already markets a test for HTLV-I alone.
HTLV-I is a retrovirus known to cause a rare form of leukemia and certain neurological disorders. HTLV-II is a retrovirus closely related to HTLV-I. Recent studies have shown that HTLV-II has a suspected association with neurologic, hematologic, ...